Behestan Darou Company
Behestan Darou Company is a Tehran-based private joint-stock pharmaceutical business within Behphar Group. It imports, registers, markets and distributes specialty medicines, biological products, hospital drugs, and rare-disease and oncology therapies across Iran. Its nationwide distribution platform and Pardis innovation centre make it a relevant route-to-market partner in Iran’s regulated pharmaceutical supply chain.
Operations & footprint
Products and services
Behestan Darou Company imports, registers, markets, and distributes pharmaceutical and healthcare products, with emphasis on specialty medicines, biological products, hospital drugs, rare-disease treatments, oncology-related therapies, and regulated healthcare supply. Its role is linked to import licensing, medical distribution, cold-chain handling, hospital procurement, and access to foreign-origin medicines.
Operations and assets
Operations encompass pharmaceutical importation, product registration, marketing and distribution. Behestan Pakhsh serves as the nationwide distribution network. The group also includes pharmaceutical-production and plasma-therapy activities, while Behestan Darou operates an Innovation Center in Pardis City.
Geographic footprint
Headquartered in Tehran, with an Innovation Center in Pardis City, Tehran Province. Its distribution network serves Iran nationwide.
Ownership & group structure
Ownership
Private Joint Stock company within Behphar Group (بهفار گروه).
Parent company
Behphar Group (بهفار گروه).
Subsidiaries and group companies
Behestan Pakhsh provides the group’s nationwide distribution network. Behestan Manufacturing is active in pharmaceutical production, while Behestan Plasma focuses on plasma-derived therapies.
Commercial and investment relevance
Behestan Darou is relevant for investors assessing Iran's pharmaceutical import dependence, specialty-drug access, hospital procurement, regulatory risk, payment constraints, and healthcare supply shortages. It can support analysis of how foreign-origin medicines enter Iran, where supply-chain bottlenecks appear, and how compliance or money-transfer limits affect healthcare availability. Due diligence should verify current distribution licenses, supplier relationships, product registrations, cold-chain capability, ownership, sanctions exposure, receivables from public or private buyers, and continuity of import channels. The company is a route to market for pharmaceutical manufacturers seeking registration, marketing and national distribution in Iran, particularly in specialty medicines, biologics, hospital drugs, rare-disease treatments and oncology therapies. Suppliers and partners benefit from its position across import, registration and distribution functions.
Constraints, risk & compliance
Key risks and constraints
Commercial continuity depends on maintaining pharmaceutical product registrations, import access and nationwide distribution for regulated specialty and biological therapies. The business is also executing a move into biopharmaceutical manufacturing and technology transfer, which adds delivery and scale-up requirements.
Need more than a public profile?
Ask Hormuz to investigate, verify or act locally around Behestan Darou Company. Tell us exactly what you need.
Connected Intelligence
Relevant geography, industry, market and execution context for this profile.
Frequently asked questions
Direct answers to the questions most likely to arise when reviewing this profile.
What does Behestan Darou Company do?
Behestan Darou imports, registers, markets and distributes pharmaceutical products, including specialty medicines, biological products, hospital drugs, and rare-disease and oncology therapies.
Where is Behestan Darou based?
The company is headquartered in Tehran, Iran, and operates an Innovation Center in Pardis City, Tehran Province.
Who owns Behestan Darou?
Behestan Darou is a private joint-stock company within Behphar Group.
How are Behestan Darou products distributed in Iran?
Behestan Pakhsh operates as the group’s nationwide distribution network.